Dynavax to Host Second Quarter 2018 Financial Results Conference Call
July 30 2018 - 2:45PM
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced
that it will report financial results for the second quarter ended
June 30, 2018 after market close on Monday, August 6, 2018, and
host a conference call that day to review the results and provide
an update on the launch of HEPLISAV-B® [Hepatitis B Vaccine,
(Recombinant) Adjuvanted] and its oncology program at 4:30pm
ET/1:30pm PT.
To access the call, participants must dial (800) 239-9838 in the
U.S. or (323) 794-2551 internationally, and use the conference ID
2303066. The live call will be webcast and can be accessed in the
"Investors and Media" section of the company's website at
www.dynavax.com. A replay of the webcast will be available for 30
days following the live event.
A replay of the conference call will be available for two weeks
and can be accessed by dialing (844) 512-2921 in the U.S. or (412)
317-6671 internationally. The conference ID for the replay will be
2303066.
About DynavaxDynavax is a fully-integrated
biopharmaceutical company focused on leveraging the power of the
body's innate and adaptive immune responses through toll-like
receptor (TLR) stimulation. Dynavax discovers and develops novel
vaccines and immuno-oncology therapeutics. The Company’s first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], was approved by the United States Food and Drug
Administration in November 2017 for prevention of infection caused
by all known subtypes of hepatitis B virus in adults age 18 years
and older. Dynavax's lead immunotherapy product, SD-101, is an
investigational cancer immunotherapeutic currently being evaluated
in Phase 1/2 studies and its second cancer immunotherapeutic,
DV281, is in Phase 1 development. For more information, visit
www.dynavax.com.
US-18-01-00346
Contact: David BurkeDirector, IR &
Corporate Communications510.665.7269dburke@dynavax.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024